| Literature DB >> 35678015 |
Chun Yang1, Huajie Ba2, Huihui Zou3, Xianju Zhou3.
Abstract
INTRODUCTION: Schizophrenia's heritability and familial transmission have been known for several decades. The male-specific Y chromosome plays an important role in schizophrenia. Short tandem repeats (STRs)have been recognized as risk genes in the development of schizophrenia. Here, we investigated the association between male schizophrenia and Y-chromosomal STRs loci.Entities:
Keywords: allele; autosomal chromosome; haplotype; schizophrenia; short tandem repeats
Mesh:
Year: 2022 PMID: 35678015 PMCID: PMC9304842 DOI: 10.1002/brb3.2637
Source DB: PubMed Journal: Brain Behav Impact factor: 3.405
Hardy–Weinberg equilibrium test for 20 STR loci in male patients and controls
| Loci | Group | χ2
| Loci | Group | χ2
|
|---|---|---|---|---|---|
| D3S1368 | Patients | χ2 = 0.52, | TH01 | Patients | χ2 = 0.15, |
| Controls | χ2 = 0.95, | Controls | χ2 = 0.01, | ||
| D1S1656 | Patients | χ2 = 0.12, | vWA | Patients | χ2 = 0.10, |
| Controls | χ2 = 0.23, | Controls | χ2 = 0.03, | ||
| D6S1043 | Patients | χ2 = 1.87, | D21S11 | Patients | χ2 = 0.38, |
| Controls | χ2 = 1.99, | Controls | χ2 = 0.06, | ||
| D13S317 | Patients | χ2 = 1.05, | D7S820 | Patients | χ2 = 0.03, |
| Controls | χ2 = 0.39, | Controls | χ2 = 1.05, | ||
| Penta E | Patients | χ2 = 0.23, | D5S818 | Patients | χ2 = 0.02, |
| Controls | χ2 = 1.37, | Controls | χ2 = 1.38, | ||
| D16S639 | Patients | χ2 = 0.13, | TPOX | Patients | χ2 = 0.00, |
| Controls | χ2 = 0.46, | Controls | χ2 = 1.72, | ||
| D18S51 | Patients | χ2 = 1.31, | D8S1179 | Patients | χ2 = 1.72, |
| Controls | χ2 = 0.02, | Controls | χ2 = 0.79, | ||
| D2S1338 | Patients | χ2 = 1.47, | D12S391 | Patients | χ2 = 1.87, |
| Controls | χ2 = 0.07, | Controls | χ2 = 2.16, | ||
| CSF1PO | Patients | χ2 = 1.07, | D19S433 | Patients | χ2 = 0.49, |
| Controls | χ2 = 0.26, | Controls | χ2 = 0.01, | ||
| Penta D | Patients | χ2 = 0.47, | FGA | Patients | χ2 = 0.61, |
| Controls | χ2 = 0.34, | Controls | χ2 = 1.57, |
Comparisons of allele frequencies of the D13S317 locus in male patients (n = 355) and controls (n = 473; frequency, %)
| Alleles | Patients | Controls | χ2 |
| Odds ratio | 95%CI |
|---|---|---|---|---|---|---|
| 8 | 197 (27.25) | 277 (29.28) | 0.47 | .4941 | 0.93 | 0.75–1.15 |
| 9 | 88 (12.39) | 122 (12.90) | 0.09 | .7612 | 0.96 | 0.71–1.28 |
| 10 | 99 (13.94) | 130 (13.74) | 0.01 | .9064 | 1.02 | 0.77–1.35 |
| 11 | 206 (29.01) | 217 (22.94) | 7.87 | .0050 | 1.37 | 1.10–1.71 |
| 12 | 96 (13.52) | 142 (15.01) | 0.73 | .3925 | 0.89 | 0.67–1.17 |
| 13 | 18 (2.4) | 44 (4.65) | 5.03 | .0248 | 0.53 | 0.31–0.93 |
|
| 11.74 | |||||
|
| .039 |
Note: The numbers in brackets indicate frequencies. Allele frequencies less than 1% in both groups were removed. The level of statistical significance for these pairwise tests was set at 0.05/6.
Comparisons of allele frequencies of the D5S818 locus in male patients (n = 355) and controls (n = 473; frequency, %)
| Alleles | Patients | Controls | χ2 |
| Odds ratio | 95%CI |
|---|---|---|---|---|---|---|
| 7 | 25 (3.52) | 10 (1.06) | 11.90 | .0006 | 3.42 | 1.63–7.16 |
| 9 | 58 (8.17) | 77 (8.14) | 0.00 | .9827 | 1.00 | 0.70–1.43 |
| 0 | 137 (19.30) | 178 (18.82) | 0.06 | .8056 | 1.03 | 0.81–1.32 |
| 11 | 218 (30.70) | 299 (31.61) | 0.15 | .6949 | 0.96 | 0.78–1.18 |
| 12 | 175 (24.65) | 231 (24.42) | 0.01 | .9145 | 1.01 | 0.81–1.27 |
| 13 | 90 (12.68) | 140 (14.80) | 1.53 | .2163 | 0.84 | 0.63–1.11 |
|
| 13.13 | |||||
|
| .022 |
Note: The numbers in brackets indicate frequencies. Allele frequencies less than 1% in both groups were removed. The level of statistical significance for these pairwise tests was set at 0.05/6.
Comparisons of genotype frequencies of the D13S317 locus in male patients (n = 355) and controls (n = 473; frequency, %)
| Genotype | Patients | Controls | χ2 |
| Odds ratio | 95%CI |
|---|---|---|---|---|---|---|
| 8‐8 | 24 (6.76) | 37 (7.82) | 0.34 | .5627 | 0.85 | 0.50–1.46 |
| 8‐9 | 28 (7.89) | 36 (7.61) | 0.02 | .8829 | 1.04 | 0.62–1.74 |
| 8‐10 | 24 (6.76) | 45 (9.51) | 2.01 | .1560 | 0.69 | 0.41–1.16 |
| 8‐11 | 51 (14.37) | 68 (14.38) | 0.00 | .9967 | 1.00 | 0.68–1.48 |
| 8‐12 | 38 (10.70) | 39 (8.25) | 1.45 | .2279 | 1.33 | 0.83–2.13 |
| 8‐13 | 7 (1.97) | 12 (2.54) | 0.29 | .5909 | 0.77 | 0.30–1.98 |
| 9‐9 | 4 (1.13) | 4 (0.85) | 0.17 | .6824 | 1.34 | 0.33–5.38 |
| 9‐10 | 9 (2.54) | 20 (4.23) | 1.72 | .1897 | 0.59 | 0.27–1.31 |
| 9‐11 | 25 (7.04) | 30 (6.34) | 0.16 | .6890 | 1.12 | 0.65–1.94 |
| 9‐12 | 14 (3.94) | 20 (4.23) | 0.04 | .8381 | 0.93 | 0.46–1.87 |
| 9‐13 | 2 (0.56) | 5 (1.06) | 0.59 | .4425 | 0.53 | 0.10–2.75 |
| 10‐10 | 4 (1.13) | 10 (2.11) | 1.19 | .2754 | 0.53 | 0.16–1.70 |
| 10‐11 | 50 (14.08) | 19 (4.02) | 26.91 | .0000002 | 3.92 | 2.27–6.77 |
| 10‐12 | 6 (1.69) | 18 (3.81) | 3.22 | .0726 | 0.44 | 0.17–1.11 |
| 11‐11 | 22 (6.20) | 32 (6.77) | 0.11 | .7432 | 0.91 | 0.52–1.60 |
| 11‐12 | 29 (8.17) | 25 (5.29) | 2.77 | .0963 | 1.59 | 0.92–2.77 |
| 11‐13 | 6 (1.69) | 11 (2.33) | 0.41 | .5234 | 0.72 | 0.26–1.97 |
| 12‐12 | 3 (0.85) | 15 (3.17) | 5.16 | .0231 | 0.26 | 0.08–0.91 |
| 12‐13 | 2 (0.56) | 7 (1.48) | 1.58 | .2081 | 0.38 | 0.08–1.83 |
|
| 47.79 | |||||
|
| .0004 |
Note: The numbers in brackets indicate frequencies. Genotype frequencies less than 1% in both groups were removed. The level of statistical significance for these pairwise tests was set at 0.05/19.
Comparisons of genotype frequencies of the D5S818 locus in male patients (n = 355) and controls (n = 473; frequency, %)
| Genotype | Subject | Controls | χ2 |
| Odds ratio | 95%CI |
|---|---|---|---|---|---|---|
| 7‐10 | 12 (3.38) | 2 (0.42) | 10.67 | .0011 | 8.24 | 1.83–37.05 |
| 7‐11 | 3 (0.85) | 6 (1.27) | 0.34 | .5609 | 0.66 | 0.17–2.67 |
| 7‐12 | 5 (1.41) | 2 (0.42) | 2.35 | .1253 | 3.36 | 0.65–17.44 |
| 9‐10 | 8 (2.25) | 12 (2.54) | 0.07 | .7926 | 0.89 | 0.36–2.19 |
| 9‐11 | 14 (3.94) | 24 (5.07) | 0.59 | .4418 | 0.77 | 0.39–1.51 |
| 9‐12 | 21 (5.92) | 24 (5.07) | 0.28 | .5971 | 1.18 | 0.64–2.15 |
| 9‐13 | 6 (1.69) | 10 (2.11) | 0.19 | .6609 | 0.80 | 0.29–2.21 |
| 10‐10 | 19 (5.35) | 18 (3.81) | 1.14 | .2864 | 1.43 | 0.74–2.77 |
| 10‐11 | 40 (11.27) | 52 (10.99) | 0.02 | .9012 | 1.03 | 0.66–1.59 |
| 10‐12 | 27 (7.61) | 42 (8.88) | 0.43 | .5116 | 0.85 | 0.51–1.40 |
| 10‐13 | 11 (3.10) | 33 (6.98) | 6.06 | .0138 | 0.43 | 0.21–0.86 |
| 11‐11 | 32 (9.01) | 48 (10.15) | 0.30 | .5847 | 0.88 | 0.55–1.40 |
| 11‐12 | 63 (17.75) | 76 (16.07) | 0.41 | .5224 | 1.13 | 0.78–1.63 |
| 11‐13 | 30 (8.45) | 41 (8.67) | 0.01 | .9120 | 0.97 | 0.59–1.59 |
| 11‐14 | 4 (1.13) | 1 (0.21) | 2.83 | .0925 | 5.38 | 0.60–48.33 |
| 12‐12 | 15 (4.23) | 32 (6.77) | 2.44 | .1180 | 0.61 | 0.32–1.14 |
| 12‐13 | 28 (7.89) | 22 (4.65) | 3.74 | .0530 | 1.76 | 0.99–3.12 |
| 13‐13 | 6 (1.69) | 16 (3.38) | 2.25 | .1340 | 0.49 | 0.19–1.27 |
| χ2 | 32.94 | |||||
|
| .011 |
Note: The numbers in brackets indicate frequencies. Genotype frequencies less than 1% in both groups were removed. The level of statistical significance for these pairwise tests was set at 0.05/18.